Session Details
[2-O]Oral Presentation
Tue. Mar 17, 2026 10:10 AM - 11:25 AM JST
Tue. Mar 17, 2026 1:10 AM - 2:25 AM UTC
Tue. Mar 17, 2026 1:10 AM - 2:25 AM UTC
Room 10(B102)
Chair:Tsugunobu Andoh(Kinjo Gakuin University), Takuya Yamaguchi(Nihon University College of Bioresource Sciences)
[2-O-11]Ghrelin signaling in the brain ameliorates the pathogenesis of myocardial infarction in mice
*Koichi Yoshida1, Daiki Masukawa1, Tomohiro Shibata1, Takeshi Tokudome1 (1. Yokohama City University School of Medicine)
[2-O-12]Establishment of a brain tumor PDX intracerebral transplant model
*Shinichiro Tsunesumi1, Misato Moriguchi1, Zhe Sun1, Shigenori Enoki1, Kosuke Morizumi1, Shigehiro Yagishita2, Akinobu Hamada2 (1. Mediford Corporation, Drug Discovery Innovation Center, Research Unit I, 2. National Cancer Center Research Institute)
[2-O-13]Development of Monoclonal Antibodies Targeting Glypican-1 via Cell-Based Immunization and Screening method
*Haruto Yamamoto1, Hiroyuki Suzuki1, Tomohiro Tanaka1, Mika K. Kaneko1, Yukinari Kato1 (1. Tohoku Univ.)
[2-O-14]TRPM2 modulates reactive oxygen species–induced cytokine production via Ca2+– and NF-κB–dependent pathways in CD11b+ but not in CD68+ Kupffer cells
*Masataka Mizuno1, Takuya Yamaguchi1, Jun Yamazaki1 (1. Lab. Vet. Pharmacol., Dept. Vet. Med., Coll. of Biores. Sci., Nihon Univ.)
[2-O-15]Involvement of tachykinin NK1 receptors in mechanical allodynia and cutaneous mast cell migration in oxaliplatin-treated mice.
*Tsugunobu Andoh1, Ayumi Kawai2 (1. Kinjo Gakuin Univ., 2. Univ. Toyama)
